1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
4.76%
Positive growth while CSIQ shows revenue decline. John Neff would investigate competitive advantages.
6.49%
Cost increase while CSIQ reduces costs. John Neff would investigate competitive disadvantage.
-2.26%
Gross profit decline while CSIQ shows 23.73% growth. Joel Greenblatt would examine competitive position.
-6.70%
Margin decline while CSIQ shows 43.87% expansion. Joel Greenblatt would examine competitive position.
-36.77%
R&D reduction while CSIQ shows 2.55% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.21%
Operating expenses reduction while CSIQ shows 10.81% growth. Joel Greenblatt would examine advantage.
3.25%
Total costs growth while CSIQ reduces costs. John Neff would investigate differences.
-22.01%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-43.36%
D&A reduction while CSIQ shows 7.58% growth. Joel Greenblatt would examine efficiency.
749.32%
EBITDA growth exceeding 1.5x CSIQ's 19.03%. David Dodd would verify competitive advantages.
710.71%
EBITDA margin growth exceeding 1.5x CSIQ's 38.41%. David Dodd would verify competitive advantages.
27.21%
Operating income growth below 50% of CSIQ's 101.26%. Michael Burry would check for structural issues.
21.43%
Operating margin growth below 50% of CSIQ's 134.04%. Michael Burry would check for structural issues.
-261.33%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-212.06%
Pre-tax income decline while CSIQ shows 92.69% growth. Joel Greenblatt would examine position.
-206.96%
Pre-tax margin decline while CSIQ shows 124.07% growth. Joel Greenblatt would examine position.
9.53%
Tax expense growth while CSIQ reduces burden. John Neff would investigate differences.
-212.19%
Net income decline while CSIQ shows 212.97% growth. Joel Greenblatt would examine position.
-207.09%
Net margin decline while CSIQ shows 263.94% growth. Joel Greenblatt would examine position.
-213.95%
EPS decline while CSIQ shows 194.74% growth. Joel Greenblatt would examine position.
-225.64%
Diluted EPS decline while CSIQ shows 188.89% growth. Joel Greenblatt would examine position.
0.14%
Share count reduction exceeding 1.5x CSIQ's 4.16%. David Dodd would verify capital allocation.
-11.05%
Diluted share reduction while CSIQ shows 13.89% change. Joel Greenblatt would examine strategy.